通过调节核酸代谢来增强血液造血干细胞和祖细胞的原始编辑
Sébastien Levesque1,2,3,4,5, Andrea Cosentino1,2,5,6, Archana Verma1,2,3,4,5
1Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
Nature biotechnology
|May 28, 2024
概括
改善血液疾病的原始编辑需要在造血干细胞中提高核酸水平. 补充脱氧核化物和降解SAMHD1可以提高这些关键细胞的编辑效率.
科学领域:
- 血液学 血液学 血液学
- 基因编辑 基因编辑
- 分子生物学分子生物学
背景情况:
- 治疗性原始编辑通过纠正血液造血干细胞和原生细胞 (HSPC) 的遗传缺陷,为治疗血液疾病提供了希望.
- 静止的HSPCs表现出低核酸池和对病毒感染的抵抗力,可能会阻碍基因编辑效率.
- 核酸代谢是一个关键因素,可能会限制HSPCs的反转录介导主要编辑.
研究的目的:
- 调查核酸代谢对HSPCs主要编辑效率的影响.
- 确定在静止的HSPC中增强主要编辑的策略.
主要方法:
- 补充脱氧核化物以增加细胞内核酸水平.
- 利用Vpx蛋白调节SAMHD1的降解,这是一个已知的核酸消耗酶.
- 采用旨在规避不匹配修复路径的主要编辑策略.
主要成果:
- 脱氧核酸补充剂显著提高了HSPC中主要编辑效率.
- 通过Vpx介导的SAMHD1降解进一步增强了主要编辑结果.
- 结合核酸补充,SAMHD1降解和不匹配修复-逃避编辑方法,在主要编辑有效性方面取得了最实质性的改进.
结论:
- 核酸的可用性是HSPC中主要编辑效率的关键决定因素.
- 通过脱氧核酸补充和SAMHD1降解来调节核酸代谢,可以克服静止HSPC中基因编辑的障碍.
- 针对核酸代谢的优化主要编辑策略具有治疗性纠正血液疾病的巨大潜力.
更多相关视频
11:16Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
Published on: February 15, 2019
7.6K
07:17Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps
Published on: July 30, 2019
7.8K
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
